Guidance Point Advisors’s Amgen AMGN Stock Holding History

Guidance Point Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18	Closed	-$3K	–	103
2021 Q3	$3K	Buy	+18	New	+$4.14K	﹤0.01%	363

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guidance Point Advisors's AMGN Position: Q4 2021 in Review

Guidance Point Advisors sold out of Amgen (AMGN) in Q4 2021, closing a stake of 18 shares — an estimated $3K sold.

Guidance Point Advisors first reported a position in AMGN in Q3 2021 and held it in 1 quarter. The position peaked at $3K in Q3 2021. 2,294 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

Guidance Point Advisors reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
Guidance Point Advisors sold 18 Amgen shares in Q4 2021, an estimated $3K.
Guidance Point Advisors first reported a position in Amgen in Q3 2021 and held it in 1 quarter.
Guidance Point Advisors's Amgen position peaked at $3K in Q3 2021.
2,294 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Guidance Point Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.